Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT04354805
Eligibility Criteria:
Inclusion Criteria:
1. Adult conscious male and female (non-pregnant, non-breast feeder), level of consciousness is assessed by Glasgow Coma Scale ≥ 13.
2. Diagnosed initially with COVID-19 confirmed with PCR prior to any interference.
3. Follow the treatment regimen for COVID-19 according to The Ministry of Health in Egypt.
Exclusion criteria:
4. Patients having allergy to chlorpromazine which will be assessed by asking the patient or relative.
5. Patients with hypotension(\<90/60mmHg).
6. Pregnant and breast feeder female patients.
7. Hepatic patients.
8. Patients already receiving chlorpromazine.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04354805
Study Brief:
Protocol Section:
NCT04354805